iQure Pharma

iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.

iQure Pharma is a global biotech company created by entrepreneurs and former pharma managers that focuses on the development of new therapeutics.

Number of Funding Rounds

Total Funding Amount

2

$600K

iQure Pharma has raised a total of $600K in funding over 2 rounds. Their latest funding was raised on Aug 31, 2022 from a Grant round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Aug 31, 2022	Grant	—	1	National Institutes of Health	—	Detail
Aug 31, 2022	Series A	$600K	2	Keiretsu Forum Mid Atlantic	—	Detail

Number of Lead Investors

Number of Investors

2

3

iQure Pharma is funded by 3 investors. National Institutes of Health and Keiretsu Forum Mid Atlantic are the most recent investors.

Investor Name	Lead Investor	Funding Round
National Institutes of Health	Yes	Grant
Keiretsu Forum Mid Atlantic	Yes	Series A
Keiretsu Forum	—	Series A